Related Experiment Videos
Using therapeutic groups to support women with faecal incontinence
Sonya Chelvanayagam1, Julian Stern
1Gastrointestinal Nursing, Burdett Institute of Gastrointestinal Nursing, St Mark's Hospital, Harrow.
Summary
Facilitated patient groups, including psychoeducational and psychotherapy sessions, effectively manage women with fecal incontinence (FI). These groups improve both psychological and physical functioning, warranting further research.
Area of Science:
- Gastroenterology
- Psychology
- Women's Health
Background:
- Fecal incontinence (FI) significantly impacts women's quality of life.
- Current management strategies may not fully address the psychological burden of FI.
Purpose of the Study:
- To describe the implementation and effectiveness of facilitated patient groups for women with FI.
- To explore the themes and outcomes of psychoeducational and psychotherapy groups.
Main Methods:
- Facilitated patient groups were utilized for FI management.
- Two group types were employed: psychoeducational and psychotherapy.
- Qualitative themes and quantitative outcomes were assessed.
Main Results:
- The study details themes emerging from group discussions.
- Facilitated groups demonstrated effectiveness in improving psychological functioning.
- Improvements in physical functioning were also observed.
Conclusions:
- Facilitated patient groups are a viable approach for managing FI in women.
- These groups offer benefits for both mental and physical well-being.
- Further investigation into group therapy for FI is recommended.
Related Concept Videos
Group Therapy
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Self-Help Support Groups
Self-help support groups are voluntary, community-based organizations that provide a platform for individuals with shared concerns to exchange support, insights, and practical strategies for coping with life challenges. Typically led by group members or paraprofessionals, these groups form a cornerstone of mental health care, especially in reaching populations that are underserved by traditional healthcare systems.
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...